https://news.cision.com/se/astrazeneca/r/airsupra–pt027–approved-in-the-us-for-asthma%2Cc3696063
Needham Downgrades Telos to Hold
Needham analyst Alex Henderson downgrades Telos (NASDAQ:TLS) from Buy to Hold.
Related Posts
Ericsson Partners With Canadian Government, To Invest CA$470M In R&D Sites
Ericsson (NASDAQ:ERIC) has inked a five-year partnership with the Government of Canada to invest CA$470 million in R&D centers across…
Microsoft, UK’s Competition And Markets Authority Seek Extension For $69B Activision Deal
In a bid to overcome opposition to its proposed $69 billion acquisition of video game maker Activision Blizzard Inc (NASDAQ: ATVI), Microsoft Corp (NASDAQ: MSFT) and the U.K.'s Competition and Markets Authority
What’s Going On With AMD Shares
Advanced Micro Devices, Inc. (NASDAQ: AMD) shares are trading higher by 3.35% to $96.81 during Friday's session.